Skip to Main Content

A pair of religious organizations that own stock in Vertex Pharmaceuticals is pressuring the company to disclose more information about its lobbying efforts, the latest bid by such groups to force the pharmaceutical industry to alter its business practices.

In a shareholder proposal, the organizations want the drug maker to report lobbying procedures and payments; membership in any organization that writes or endorses legislation, such as industry trade groups; and management policies for overseeing lobbying (see page 37).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED